A research firm released an update on Ensysce Biosciences, noting the company received a $5.3 million installment for a platform study conducted in collaboration with a CRO.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A research firm released an update on Ensysce Biosciences, noting the company received a $5.3 million installment for a platform study conducted in collaboration with a CRO.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Ensysce Biosciences announced that on July 16, 2025, Rho, Inc. was selected as their clinical research partner.Sub-event
Ensysce Biosciences received a $5.3 million installment for a platform study.1 source
Keep exploring
The entities involved
-
Ensysce Biosciences
company in La Jolla, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireDiamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC) New York, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a foc